ZOETIS EXECUTIVE TEAM
Clinton Lewis, Jr.
Executive Vice President and Group President, International Operations, Commercial Development, Genetics and PHARMAQ
Clint Lewis is executive vice president and group president responsible for International Operations, Commercial Development and Lifecycle Innovation, Global Genetics and PHARMAQ at Zoetis. In this role, he is responsible for all markets outside the United States. Mr. Lewis also oversees the company’s global commercial development and new product strategy, as well as the Global Genetics business and PHARMAQ, the company’s aquaculture business.
Mr. Lewis previously served as president, International Operations at Zoetis (2015-2018) and president, U.S. Operations at Zoetis (2013-2015). Prior to the formation of Zoetis, he served as president, U.S. Operations, for Pfizer Animal Health, which he joined in 2007.
Mr. Lewis joined Pfizer in 1988 as a sales representative in the human health pharmaceutical segment, and held positions of increasing responsibility across various commercial and general management roles dedicated to human health.
In addition to his responsibilities at Zoetis, Mr. Lewis served as the former vice chair and chairman for the Animal Health Institute (AHI), the trade association for the animal health industry in the U.S. (2009-2012). He also served as the treasurer for Animal Health Europe, the trade association for the animal health industry in Europe (2016-2018).
Mr. Lewis serves as a member of the Board of Directors for International Paper, where he is a member of the Governance and Public Policy, Environment and Sustainability sub committees.
Mr. Lewis has been recognized by Black Enterprise Magazine as one of its 300 Most Powerful Executives, and by Savoy magazine as one of its Top 100 most influential African-Americans in Corporate America.
Mr. Lewis holds a bachelor's degree in biology from Fairfield University and a Master of Business Administration in marketing from Fairleigh Dickinson University.